Cardiovascular Diseases
At Muenchen Klinik gGmbH, the cardiology team is investigating innovative approaches to manage heart attacks, focusing on patients at risk of a recurrent event. The study evaluates the effectiveness of a self‑administered medication to quickly address symptoms of acute myocardial infarction, aiming to improve early treatment outcomes and reduce hospital admissions.
- Early patient‑initiated therapy for heart attacks
- Assessment of real‑world effectiveness
- Safety monitoring of self‑administration
- Impact on recurrent cardiovascular events
- Integration of emergency response protocols
The research involves a multidisciplinary team of 13 investigators and leverages the hospital’s intensive care expertise in Munich to advance cardiovascular care.
Neoplasms
The oncology department is conducting cutting‑edge trials in metastatic colorectal cancer, particularly in patients whose tumors exhibit MSI‑High or mismatch repair deficiency. By testing novel immunotherapy combinations, including agents such as MK‑1308A alongside established checkpoint inhibitors, the goal is to enhance tumor response rates and provide new treatment options for advanced disease.
- Biomarker‑driven immunotherapy strategies
- Combination regimens to boost response
- Evaluation of objective response per RECIST
- Safety and tolerability of new agents
- Optimizing dosing for targeted therapies
With 13 dedicated investigators, the Munich site is positioned to contribute valuable data to the global effort against colorectal cancer.
